GlobeNewswire
Contact Us
Register
Sign In
English
Français
About this file
Figure 3
GeneSight Improved Outcomes for Patients Switching Medications
Myriad Genetics, Inc.
Format
PNG
Source
Myriad Genetics, Inc.
Downloads
Original
Large
Medium
Small
ASSOCIATED PRESS RELEASE
GeneSight® Psychotropic Test Improved Clinical Outcomes for People with Depression Who Were Taking Medications with Gene-Drug Interactions
Published
November 06, 2019 07:05 ET